Aramis Biotechnologies
PrivateLast Round
Debt
Dec 6, 2024
Total Funding Raised
$56.13M
Momentum Score
25 /100
Company Overview
Aramis Biotechnologies is a biotechnology company that specializes in the production of innovative vaccines in plants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aramis Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
Aramis Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 6, 2024 | ||||
| Debt | Dec 5, 2024 | ||||
| Series A | Dec 4, 2024 |
Key People
Founding team and executive leadership
Aramis Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation, Science and Economic Development Canada | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2025
Presented at the inaugural Scientific Horizon event.
- Jun 12, 2025
Unveiled breakthroughs in plant-based protein production at Scientific Horizon.
Aramis Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aramis Biotechnologies's valuation, stock price, and market status.
